The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc. NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the closing of an Initial Public Offering for CNS Pharmaceuticals, Inc. of 2,125,000 shares of common stock at...

Dawson James Securities Announces the Closing of IMAC Holdings, Inc. NASDAQ Initial Public Offering at $5.125 per Unit BOCA RATON, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. in conjunction with IMAC Holdings, Inc. (Nasdaq: IMAC) announced today the closing of its firm commitment...